Intestinal Cell News Volume 2.07 | Feb 26 2016

    0
    20

    Intestinal Cell News 2.07 February 26, 2016

    Intestinal Cell News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  ICN on Twitter

     
    TOP STORY
    Transcriptional Reprogramming and Resistance to Colonic Mucosal Injury in Poly(ADP-Ribose) Polymerase 1 (PARP1)-Deficient Mice
    Researchers identified REGγ-mediated control of IκBε as a molecular mechanism that contributes to NFκB activation and promotes bowel inflammation and associated tumor formation in response to chronic injury. [Nat Commun] Full Article
    Watch Now: Webinar on Gastrointestinal Organoids by Dr. Meritxell Huch

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    INTESTINAL CANCERS & DISEASES

    Tumor Suppressive Role of Sestrin2 during Colitis and Colon Carcinogenesis
    Investigators showed that human SESN2 expression is elevated in the colon of ulcerative colitis patients but is lost upon p53 inactivation during colon carcinogenesis. [eLife] Full Article | Download Full Article

    Novel Role of STRAP in Progression and Metastasis of Colorectal Cancer through Wnt/β-Catenin Signaling
    Researchers showed the molecular mechanism by which Serine-Threonine Kinase Receptor-Associated Protein (STRAP) induces colorectal cancer metastasis by promoting β-catenin signaling through its stabilization. [Oncotarget] Full Article

    Long Non-Coding RNA MALAT1 Increases AKAP-9 Expression by Promoting SRPK1-Catalyzed SRSF1 Phosphorylation in Colorectal Cancer Cells
    Researchers investigated the molecular mechanism by which MALAT1 enhances AKAP9 expression in colorectal cancer SW480 cells. They found that MALAT1 interacts with both SRPK1 and SRSF1. [Oncotarget] Full Article

    The miR-27a-Calreticulin Axis Affects Drug-Induced Immunogenic Cell Death in Human Colorectal Cancer Cells
    The authors sought to verify whether miR-27a is implicated in immunogenic cell death, having demonstrated that it directly targets calreticulin. [Cell Death Dis] Full Article

    The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF-1 Is Responsible for the Development of Colon Cancer with Type 2 Diabetes Mellitus
    The authors investigated the effects and mechanisms of insulin and insulin-like growth factor 1 (IGF-1) in colon cancer development in vitro and in vivo. Insulin and IGF-1 alone or together elevated proliferation and reduced apoptosis in colon cancer MC38 cells. [PLoS One] Full Article

    INTESTINAL STEM CELL & ORGANOID RESEARCH

    Sex Difference in Pathology of the Aging Gut Mediates the Greater Response of Female Lifespan to Dietary Restriction
    Investigators uncovered a substantial sex difference in the pathology of the aging gut in Drosophila. The intestinal epithelium of the aging female undergoes major deterioration, driven by intestinal stem cell (ISC) division, while lower ISC activity in males associates with delay or absence of pathology, and better barrier function, even at old ages. [eLife] Full Article

    Quantifying Lgr5-Positive Stem Cell Behavior in the Pyloric Epithelium
    Using in vivo lineage tracing data researchers quantified clonal expansion as well as proliferation and differentiation of the Lgr5-positive stem cell population in pyloric gastric glands. [Sci Rep] Full Article

    A Versatile Strategy for Isolating a Highly Enriched Population of Intestinal Stem Cells
    Scientists introduce a combinational cell surface marker-mediated strategy that allows the isolation of an intestinal stem cell (ISC) population transcriptionally and functionally equivalent to the gold standard Lgr5-GFP ISCs. [Stem Cell Reports] Full Article | Graphical Abstract

    Learn More: STEMdiff™ Pancreatic Progenitor Kit

     
    REVIEWS
    Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease
    The authors discuss how novel insights into the mechanism of action of anti-TNFs in Crohn’s disease may contribute to the development of novel anti-TNFs with improved efficacy. [J Crohns Colitis] Abstract

    Visit our reviews page to see a complete list of reviews in the intestinal cell research field.

     
    INDUSTRY NEWS
    TiGenix Obtains Commercial Production License for Cx601
    TiGenix NV announced that it has successfully obtained the license for commercial production of Cx601, TiGenix’s product for the treatment of complex perianal fistulas in Crohn’s disease patients. [TiGenix NV] Press Release

    Atlantic Healthcare Starts Pivotal Phase III trial of Alicaforsen to Treat Inflammatory Bowel Disease Pouchitis
    Atlantic Healthcare Plc announced that patient recruitment has commenced for a Phase III trial of its wholly-owned product alicaforsen enema to treat inflammatory bowel disease pouchitis. [Atlantic Healthcare plc] Press Release

    Government of Canada Invests in Research Commercialization
    The Centre for Commercialization of Cancer Immunotherapy will receive funding of $15 million over five years to develop, translate and commercialize cancer immunotherapy. [Networks of Centres of Excellence of Canada] Press Release

    From our sponsor: 3D intestinal organoid culture is made easy with IntestiCult™. Request a sample.

     
    POLICY NEWS
    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW European Society for Medical Oncology (ESMO) 2016
    October 7-11, 2016
    Copenhagen, Denmark

    Visit our events page to see a complete list of events in the intestinal cell research community.

     
    JOB OPPORTUNITIES
    NEW Faculty Position – Cancer Research (Texas Tech University Health Sciences Center)

    Postdoctoral Position – Immunology of Inflammatory Bowel Disease (University of California, San Diego)

    Postdoctoral Fellowship – Inflammatory Bowel Disease (Linköping University)

    Postdoctoral Position – Tumor Immunology (Medical University of South Carolina)

    Research Associate – Autoimmunity (The Scripps Research Institute)

    Postdoctoral Fellowship – Immunology (Beth Israel Deaconess Medical Center)

    Gastroenterologist – Inflammatory Bowel Disease (Mayo Clinic)

    Postdoctoral Associate – Biomedical and Single Cell Genomics (Cornell University)

    Faculty Position – Gastrointestinal Physiology (University of Ottawa)

    Postdoctoral Position – Gut Inflammation and IBD (University College Cork)


    Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Intestinal Cell News? Click here to submit!

    Comments or suggestions? Submit your feedback here

    Learn more about Intestinal Cell News: Archives | Events | Contact Us